BMO Financial Group plans $25M share repurchase via normal course bid
- BMO intends to repurchase up to 25 million common shares for cancellation
- The bid represents approximately 3.6% of the public float as of July 31, 2026
- Program requires approval from OSFI and the Toronto Stock Exchange
- Purchases would run from Sept. 8, 2026, to Sept. 7, 2027, if approved
- Total outstanding shares stand at 697,146,398 as of late July 2026

*this image is generated using AI for illustrative purposes only.
Bank of Montreal (TSX: BMO) (NYSE: BMO) announced on Aug. 25, 2026, its intention to repurchase up to 25 million common shares for cancellation. The move aims to provide additional flexibility in managing the bank’s capital position.
Bid Structure and Timeline
The proposed normal course issuer bid is subject to approval from the Office of the Superintendent of Financial Institutions Canada (OSFI) and the Toronto Stock Exchange (TSX). If approved, the bid would commence on or around September 8, 2026, and conclude on September 7, 2027.
Purchases will primarily occur through TSX facilities but may also include transactions on other designated exchanges, alternative Canadian trading systems, or via private agreements permitted by securities regulatory authorities. This includes automatic purchase plans and block purchases under exemption orders.
Share Count and Market Impact
As of July 31, 2026, BMO had 697,146,398 common shares issued and outstanding. The public float stood at 696,863,163 shares. The proposed repurchase of 25 million shares represents approximately 3.6% of this public float.
| Metric | Value |
|---|---|
| Shares to be repurchased | Up to 25 million |
| Outstanding shares (July 31, 2026) | 697,146,398 |
| Public float (July 31, 2026) | 696,863,163 |
| Percentage of public float | 3.6% |
Pricing and Execution
Except for purchases made under exemption orders—which are generally executed at a discount to the prevailing market price—the bank will pay the market price for shares at the time of acquisition. The timing and volume of purchases remain at management’s discretion, contingent on market conditions and regulatory approvals.
This bid replaces the current normal course issuer bid, which commenced on September 5, 2025, and continues until September 4, 2026.
How might the repurchase of 3.6% of BMO's public float impact its earnings per share (EPS) and return on equity (ROE) metrics over the next fiscal year?
What does this capital allocation decision signal about management's confidence in BMO's current valuation and future growth prospects compared to dividend increases or M&A activity?
How could regulatory approval timelines from OSFI influence market sentiment and share price volatility between the announcement in August 2026 and the bid commencement in September 2026?



























